GB201416716D0 - Use - Google Patents

Use

Info

Publication number
GB201416716D0
GB201416716D0 GBGB1416716.7A GB201416716A GB201416716D0 GB 201416716 D0 GB201416716 D0 GB 201416716D0 GB 201416716 A GB201416716 A GB 201416716A GB 201416716 D0 GB201416716 D0 GB 201416716D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1416716.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NovaBiotics Ltd
Original Assignee
NovaBiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NovaBiotics Ltd filed Critical NovaBiotics Ltd
Priority to GBGB1416716.7A priority Critical patent/GB201416716D0/en
Publication of GB201416716D0 publication Critical patent/GB201416716D0/en
Priority to PCT/GB2015/052713 priority patent/WO2016046523A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1416716.7A 2014-09-22 2014-09-22 Use Ceased GB201416716D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1416716.7A GB201416716D0 (en) 2014-09-22 2014-09-22 Use
PCT/GB2015/052713 WO2016046523A1 (en) 2014-09-22 2015-09-21 Use of cystamine for treating bacterial and fungal infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1416716.7A GB201416716D0 (en) 2014-09-22 2014-09-22 Use

Publications (1)

Publication Number Publication Date
GB201416716D0 true GB201416716D0 (en) 2014-11-05

Family

ID=51869289

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1416716.7A Ceased GB201416716D0 (en) 2014-09-22 2014-09-22 Use

Country Status (2)

Country Link
GB (1) GB201416716D0 (en)
WO (1) WO2016046523A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201510077D0 (en) * 2015-06-10 2015-07-22 Novabiotics Ltd Use
GB201609940D0 (en) * 2016-06-07 2016-07-20 Novabiotics Ltd Microparticles
US10905660B2 (en) 2016-06-07 2021-02-02 Novabiotics Limited Microparticles
IL263540B2 (en) * 2016-06-07 2023-07-01 Novabiotics Ltd Microparticles comprising a sulphur-containing compound
WO2017212239A1 (en) * 2016-06-07 2017-12-14 Novabiotics Limited Treatment of drug-resistant microbial infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063226A1 (en) * 2003-12-19 2005-07-14 Omega Bio-Pharma (I.P.3) Limited Compositions and methods for treating diabetes
WO2008092262A1 (en) * 2007-01-31 2008-08-07 The Royal Institution For The Advancement Of Learning/Mcgill University Methods and compounds for treatment, prevention and diagnosis of parasitic infection and disease
WO2009076722A1 (en) * 2007-12-19 2009-06-25 The University Of Melbourne Method of protecting a surface from biological fouling
GB201021186D0 (en) * 2010-12-14 2011-01-26 Novabiotics Ltd Composition
WO2013103780A1 (en) * 2012-01-06 2013-07-11 Trustees Of Boston University Compositions and methods to boost endogenous ros production from bacteria

Also Published As

Publication number Publication date
WO2016046523A1 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
DK3237446T3 (en) Anti-PD-1-antistoffer
DK3236972T3 (en) Antivirale N4-hydroxycytidin-derivativer
DK3373003T3 (en) Urinteststrimmel
AU361515S (en) Dishrack
AU362944S (en) Lapboard
GB201412290D0 (en) Novel use
GB201403944D0 (en) New use
DK3191586T3 (en) Cellobiosephosphorylase
DK3178931T3 (en) Anti-orai1-antistof
GB201416727D0 (en) Use
GB201416716D0 (en) Use
DK3002465T3 (en) Hydrauliksystem
GB201417497D0 (en) Novel use
DK3194944T3 (en) Tomografiapparat
GB201420095D0 (en) New use
DK3145380T3 (en) Toiletventilationssystem
DK3234061T3 (en) Nano-inhibitorer
GB201417499D0 (en) Novel use
AU5585P (en) Lanutah Mandevilla sanderi
AU5593P (en) Lanmissouri Mandevilla sanderi
AU5594P (en) Lanoregon Mandevilla sanderi
AU5598P (en) Lanidaho Mandevilla sanderi
AU5596P (en) Lannevada Mandevilla sanderi
AU5597P (en) Lancalifornia Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)